Panelists discuss how decisions to switch between Bruton tyrosine kinase (BTK) inhibitors are driven by multiple factors including intolerable toxicities, development of resistance mutations, disease ...
Panelists discuss how the inclusion of ibrutinib on the Inflation Reduction Act (IRA) negotiated drug price list could make it a more economically attractive first-line option, potentially influencing ...
Verywell Health on MSN12h
New FDA-Approved Painkiller Is a Safer Alternative to OpioidsThe FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.
Updated recommendations were issued by the IAS-USA regarding the use of ART for treatment and prevention of HIV in adult populations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback